Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Diagnostics In 2014: More Of The Same

Jan 21 2015

Related Content

Companion Diagnostics Guidance Finalized, But Lab Test Enforcement To Be Key

Aug 04 2014

Illumina’s Unique Leverage In NIPT

Sep 10 2013

FDA Plan To Regulate LDTs Includes Long Phase-In, Unmet-Need Exceptions

Jul 31 2014

When Illumina Buys Roche: The Dawning Of The Era Of Diagnostics Dominance

Jul 28 2014

2013: The Year In Diagnostics

Jan 17 2014

Option Deal Structure Works For Myriad As It Moves To Buy Crescendo

Feb 10 2014

Philips Increases Bet On Imaged-Guided Therapy With Volcano Buy

Dec 17 2014

Parallel Review Progress: FDA Approves, CMS Assesses <em>Cologuard </em>Cancer Test

Aug 12 2014

Related Companies

Myriad Genetics, Inc.

Exact Sciences Corp.

Illumina, Inc.

Thermo Fisher Scientific

AstraZeneca PLC

Johnson & Johnson

Johnson & Johnson

Sanofi

GSK plc

Pfizer Inc.

Illumina, Inc.

Roche Holding AG

Horizon Discovery Ltd

T2 Biosystems, Inc.

CareDx, Inc

Myriad Genetics, Inc.

Myriad Genetics, Inc.

IQuum Inc.

Roche Holding AG

Roche Holding AG

Fluidigm Corp.

DVS Sciences Inc.

Ortho Clinical Diagnostics Inc.

Royal Philips

Volcano Corporation

Additional Topics

Strategy Business Strategies Personalized Medicine Regulation Deals Medical Device

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window